HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Marketing In Brief

This article was originally published in The Rose Sheet

Executive Summary

Hollywood Lips: New Hollywood Lips Plumping Balm mixes "science with seduction and superstars," according to founder and creator Bret Boreman. Boreman, an L.A.-based makeup artist, launched the line in April at Hollywood boutiques such as Kitson. The line comprises three Plumping Balms - in coconut, tangerine and passion fruit - that rely on shea butter and safflower oil, among other ingredients, to "plump and perfect" lips. The collection also features three lip treatments including Sweet Sugar Scrub, an orange-flavored lip exfoliant, and two moisturizers - Hydrating Night Balm, and Soothing Day Relief - to prep, heal and repair lips prior to plumping. The items are available for individual sale - the balms for $9.95, the scrub for $7 and the moisturizers for $8 - at select boutiques and are available in two- and three-item sets online at 1www.hollywoodlipsonline.com...
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

RS014849

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel